Indivior Q2 2026 Earnings Call: Complete Transcriptbenzinga_article·Aug 17 at 04:19 AMSUPN-3.37%INDV-2.41%
Key deals this week: Bending Spoons, Advanced Micro Devices, Visa, Prologis, and morebusinessinsider·Aug 9 at 09:59 AMATKR+0.12%LNTH-0.27%
Supernus and Indivior merge to create scaled, CNS-focused entityPharmaceutical Technology·Aug 4 at 05:57 AMSUPN-3.37%INDV-2.41%
Supernus, Indivior agree all-stock merger, combined firm to trade as Supernus on NasdaqPUBT·Aug 3 at 05:31 AMSUPN-3.37%INDV-2.41%
Addex Therapeutics Reports Q1 2026 Results: Full Earnings Call Transcriptbenzinga_article·Jun 25 at 10:00 AMADXN+8.10%INDV
Is It Time To Reassess Indivior Pharmaceuticals (INDV) After Its 200% One Year Surge?Simplywall·Mar 30 at 08:53 AMBIB+2.74%XBI+1.44%
Indivior Pharmaceuticals shares are trading lower after the company announced its intention to commence a $400 million senior notes offering.benzinga_article·Mar 12 at 01:25 PMINDV-2.41%INDV
